SmofKabiven Electrolyte Free Emulsion for Infusion
Product details
Registration number: SIN14292P
Classification: Prescription Only
Active ingredients:
- Alanine
- Arginine
- Fish oil, rich in omega -3 acids
- Glucose monohydrate
- Glycine
- Histidine
- Isoleucine
- Leucine
- Lysine Acetate
- Methionine
- Olive oil, refined
- Phenylalanine
- Proline
- Serine
- Soya bean oil, refined
- Taurine
- Threonine
- Triglycerides, Medium Chain
- Tryptophan
- Tyrosine
- Valine
Strength:
- 14.0g/1000ml
- 12.0g /1000ml
- 30g /1000ml
- 462g /1000ml
- 11.0g /1000ml
- 3.0g /1000ml
- 5.0g /1000ml
- 7.4g /1000ml
- 9.3g /1000ml
- 4.3g /1000ml
- 50g /1000ml
- 5.1g /1000ml
- 11.2g /1000ml
- 6.5g /1000ml
- 60.0g /1000ml
- 1.0g /1000ml
- 4.4g /1000ml
- 60g /1000ml
- 2.0g/1000ml
- 0.4g /1000ml
- 6.2g /1000ml
Dosage form: INJECTION, EMULSION
Route: INTRAVENOUS
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
ATC code: B05BA10
HSA approval date: 16 January 2013
Manufacturer(s):
- Fresenius Kabi AB
- Fresenius Kabi Austria GmbH
Manufacturing country/countries: SWEDEN; AUSTRIA
What are the HSA registration number and classification for SmofKabiven Electrolyte Free Emulsion for Infusion?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14292P
Classification: Prescription Only
What active ingredients and strength are recorded for SmofKabiven Electrolyte Free Emulsion for Infusion?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Alanine
- Arginine
- Fish oil, rich in omega -3 acids
- Glucose monohydrate
- Glycine
- Histidine
- Isoleucine
- Leucine
- Lysine Acetate
- Methionine
- Olive oil, refined
- Phenylalanine
- Proline
- Serine
- Soya bean oil, refined
- Taurine
- Threonine
- Triglycerides, Medium Chain
- Tryptophan
- Tyrosine
- Valine
Strength:
- 14.0g/1000ml
- 12.0g /1000ml
- 30g /1000ml
- 462g /1000ml
- 11.0g /1000ml
- 3.0g /1000ml
- 5.0g /1000ml
- 7.4g /1000ml
- 9.3g /1000ml
- 4.3g /1000ml
- 50g /1000ml
- 5.1g /1000ml
- 11.2g /1000ml
- 6.5g /1000ml
- 60.0g /1000ml
- 1.0g /1000ml
- 4.4g /1000ml
- 60g /1000ml
- 2.0g/1000ml
- 0.4g /1000ml
- 6.2g /1000ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for SmofKabiven Electrolyte Free Emulsion for Infusion?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, EMULSION
Route: INTRAVENOUS
Who is the recorded registrant for SmofKabiven Electrolyte Free Emulsion for Infusion?
According to the HSA dataset updated 7 August 2026:
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for SmofKabiven Electrolyte Free Emulsion for Infusion?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Fresenius Kabi AB
- Fresenius Kabi Austria GmbH
Manufacturing country/countries: SWEDEN; AUSTRIA
Where can I look up SmofKabiven Electrolyte Free Emulsion for Infusion in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14292P or the exact product name SmofKabiven Electrolyte Free Emulsion for Infusion. The general register link does not preselect this product.
What are the source dates for this SmofKabiven Electrolyte Free Emulsion for Infusion record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this SmofKabiven Electrolyte Free Emulsion for Infusion record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14292P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)